| Filed | Form | Description | |
|---|---|---|---|
| 5/21/24 | SC 13D/A | SC 13D/A | → |
| 2/14/24 | SC 13G/A | SC 13G/A | → |
| 2/14/24 | SC 13G/A | SC 13G/A CELLECTIS | → |
| 12/5/23 | SC 13G/A | SC 13G/A | → |
| 11/16/23 | SC 13D/A | SC 13D/A | → |
| 11/13/23 | SC 13D/A | SC 13D/A | → |
| ↓ | |||
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.